介质干细胞在调节多发性硬化症适应性免疫反应中的作用
Sepehr Dadfar1,2, Esmaeil Yazdanpanah1, Alireza Pazoki1,2
1Student Research Committee, Semnan University of Medical Sciences, Semnan 35147-99442, Iran.
Cells
|September 27, 2024
概括
介质细胞干细胞 (MSCs) 通过调节免疫系统和帮助再生,显示出治疗多发性硬化症 (MS) 的前景. 然而,MSC面临的挑战是:
科学领域:
- 神经免疫学 神经免疫学
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 多发性硬化症 (MS) 是一种慢性中枢神经系统自身免疫性疾病,导致神经退行和残疾.
- 目前的MS治疗方法有限,需要新的治疗策略.
- 介酶干细胞 (MSC) 显示出与MS相关的免疫调节和再生潜力.
研究的目的:
- 审查多发性硬化症 (MS) 的病原性.
- 探索介质干细胞 (MSC) 对多发性硬化症的治疗潜力.
- 确定MSC在MS中的临床应用的挑战和策略.
主要方法:
- 关于多发性硬化症发病的文献综述,重点关注免疫细胞 (例如T细胞) 的作用.
- 在MS的动物模型中检查MSC有效性的临床前数据.
- 对阻碍MSC治疗MS的临床转化挑战的分析.
主要成果:
- 临床前研究表明MSCs在MS动物模型中的有效性.
- 关键的挑战包括捐赠者的变异性,培养条件,迁移和免疫学兼容性.
- 建议采用基因改造和优化分娩等策略来克服这些障碍.
结论:
- 由于MSC的特性,MSC对多发性硬化症 (MS) 具有治疗前景.
- 为了成功地将MSC治疗转化为临床治疗,必须应对重大挑战.
- 进一步的研究对于验证MSC用于MS治疗至关重要.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
T Cell Types and Functions
960
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
960
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


